Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
An RCT to treat learning impairment in multiple sclerosis: The MEMREHAB trial.
Structure and inhibition of herpesvirus DNA packaging terminase nuclease domain.
Pediatric Multiple Sclerosis with Primary Progressive Course-Report of a Retrospective Cohort Study in Iran.
Aurintricarboxylic Acid Ameliorates Experimental Autoimmune Encephalomyelitis by Blocking Chemokine-Mediated Pathogenic Cell Migration and Infiltration.
Nicotine might have a protective effect in the etiology of multiple sclerosis.
Early versus delayed treatment with laquinimod demonstrated significant reduction in risk of disability progression – Results of three-year ALLEGRO study in relapsing-remitting multiple sclerosis
Cortical reorganization in multiple sclerosis after intrathecal baclofen therapy.
Defining Encephalopathy in Acute Disseminated Encephalomyelitis.
Bone health and multiple sclerosis.
Induction of multiple sclerosis and response to tyrosine kinase inhibitors.
Mechanisms and Pharmacology of Neuropathic Pain in Multiple Sclerosis.
How much sunlight is enough?
Walking capacity and ability are more impaired in progressive compared to relapsing type of multiple sclerosis.
Immunomodulation by statins: inhibition of cholesterol vs. isoprenoid biosynthesis.
Statin treatment of adult human glial progenitors induces PPAR gamma-mediated oligodendrocytic differentiation.
Perivascular spaces in MS patients at 7 Tesla MRI: A marker of neurodegeneration?
P2Y12 Receptor on the Verge of a Neuroinflammatory Breakdown.
Aquatic training in MS: neurotherapeutic impact upon quality of life.
Cost Effectiveness of Oromucosal Cannabis-Based Medicine (Sativex®) for Spasticity in Multiple Sclerosis.
Evaluation of Inner Retinal Layers in Patients with Multiple Sclerosis or Neuromyelitis Optica Using Optical Coherence Tomography.
Environmental factors and their regulation of immunity in multiple sclerosis.
[2012: news in neurology].
[Laquinimod is an oral drug with a marked neuroprotective effect for pathogenetic treatment of multiple sclerosis(review)].
The use of Doppler ultrasound in the diagnosis of chronic cerebrospinal venous insufficiency.
[Neuromyelitis optica in children. Two case reports.]
Pages
« first
‹ previous
…
272
273
274
275
276
277
278
279
280
…
next ›
last »